Terkko Navigator / Hematology/ Feeds

Liquid biopsy beyond of cancer: Circulating pulmonary cells as biomarkers of COPD aggressivity

Modern radiotherapy in cancer treatment during pregnancy

Kainate receptor auxiliary subunit NETO2 is required for normal fear expression and extinction.

Tricarboxylic acid cycle metabolites in the control of macrophage activation and effector phenotypes

The role of CNS macrophages in streptococcal meningoencephalitis

Frontline Science: Induction of experimental autoimmune encephalomyelitis mobilizes Th17‐promoting myeloid derived suppressor cells to the lung

Dispensable role of chemokine receptors in migration of mycobacterial antigen-specific CD4+ T cells into Mycobacterium-infected lung

The role of autoimmunity in women with type 1 diabetes and adverse pregnancy outcome: a missing link

Early colorectal cancer: diagnosis, treatment and survivorship care

Special Issue on pluripotent stem cells and hematopoiesis.

Vorinostat synergizes with Antioxidant therapy to target Myeloproliferative Neoplasms.

Tricarboxylic acid cycle metabolites in the control of macrophage activation and effector phenotypes

Anti‐N and anti‐Doa immunoglobulin G alloantibody–mediated delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease treated with eculizumab and HBOC‐201: case report and review of the literature

Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma

Characterization and treatment of congenital thrombotic thrombocytopenic purpura

Increased galactose expression and enhanced clearance in patients with Low von Willebrand factor

Aberrant Wnt signaling in multiple myeloma: molecular mechanisms and targeting options

Unleash the power of the mighty T cells-basis of adoptive cellular therapy

Expert consensus on multidisciplinary therapy of colorectal cancer with lung metastases (2019 edition)

Clinical trials of dual-target CAR T cells, donor-derived CAR T cells, and universal CAR T cells for acute lymphoid leukemia

The role of CNS macrophages in streptococcal meningoencephalitis

Frontline Science: Induction of experimental autoimmune encephalomyelitis mobilizes Th17‐promoting myeloid derived suppressor cells to the lung

Effects of therapeutic plasma exchange on anticoagulants in patients receiving therapeutic anticoagulation: a systematic review

Introduction to a review series on advances in multiple myeloma

Megakaryocytes from fat: a new recipe for platelets

IDH2 inhibition: another piece to the puzzle

Off-target effects of carfilzomib that cause cardiotoxicity

Yet another susceptibility variant for ALL: whats next?

More than one pathway: novel treatment for ITP

Hepatocyte tPA: where have you been hiding?

Megakaryocytes and platelets from a novel human adipose tissue-derived mesenchymal stem cell line

Imaging in multiple myeloma: How? When?

Pros and cons of frontline autologous transplant in multiple myeloma: the debate over timing

Toward personalized treatment in multiple myeloma based on molecular characteristics

Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib

Serial transplantation reveals a critical role for endoglin in hematopoietic stem cell quiescence

GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts

Molecular mechanisms of carfilzomib-induced cardiotoxicity in mice and the emerging cardioprotective role of metformin

Novel susceptibility variants at the ERG locus for childhood acute lymphoblastic leukemia in Hispanics

Low-dose chidamide restores immune tolerance in ITP in mice and humans

An ATF6-tPA pathway in hepatocytes contributes to systemic fibrinolysis and is repressed by DACH1

The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases

Staging systems use for risk stratification of systemic amyloidosis in the era of high-sensitivity troponin T assay

Intraocular toxoplasmosis mimicking vitreous lymphoma

Porpaczy E, Tripolt S, Hoelbl-Kovacic A, et al. Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy. Blood. 2018;132(7):694-706.

Current challenges for CAR T‐cell therapy of acute myeloid leukemia

Tackling molecular targets beyond PD-1/PD-L1: Novel approaches to boost patients’ response to cancer immunotherapy

Outcomes and risk factors of massive and submassive pulmonary embolism in children: a retrospective cohort study

Paediatric pulmonary embolism: a pathway to improved outcomes

In Reply to the Letter to the Editor from Ramkisoensing: Young Versus Adult: Finding Clues to Unravel the Increased Regenerative Ability of Stem Cells from Young Donors